Vimarsana
Biggest News Aggregation in the World

Kofi Essel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kofi Essel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kofi Essel Today - Breaking & Trending Today

'Food Equity Can't Be a Side Gig': How Food as Medicine is Becoming A Core Team Capability - Vimarsana News

'Food Equity Can't Be a Side Gig': How Food as Medicine is Becoming A Core Team Capability

As the food as medicine movement grows, some payers and healthcare organizations are carving out specific roles and teams dedicated to food and nutrition. Doing so can be beneficial considering the significant impact diet can have on health outcomes.

In West Africa, food poisoning is silently on the prowl - Vimarsana News

In West Africa, food poisoning is silently on the prowl

SciDevNet uncovers the ‘silent killer’ of food and water contamination in West Africa, as statistics show related hospital outpatient cases.

Source: scidev.net
Doctors need better training to encourage healthier eating | Agri-Pulse Communications, Inc. - Vimarsana News

Doctors need better training to encourage healthier eating | Agri-Pulse Communications, Inc.

Despite overwhelming evidence that poor diets contribute to preventable illness and many leading causes of death – heart disease, cancer and Type 2 diabetes – doctors and other health professionals get little training in nutrition in medical school and other education.

Gospel singer Nacee kicks against FDA ban on celebrities not to advertise alcohol - Vimarsana News

Gospel singer Nacee kicks against FDA ban on celebrities not to advertise alcohol

Gospel artist Nacee expressed his disagreement with the decision by the Food and Drugs Authority to prohibit Ghanaian celebrities from endorsing alcoholic products. | Pulse Ghana

More RSV shots for infants on the way - Vimarsana News

More RSV shots for infants on the way

More than 77,000 doses of a monoclonal antibody shot that protects infants from severe respiratory syncytial virus are headed to providers.